Seevix Material Sciences Ltd. (“Seevix”), which develops and manufactures synthetic SVX™ spidersilk, announced today that ASICS Ventures Corporation has invested in Seevix. SVX™ possesses natural spidersilk’s extraordinary strength and elasticity and is durable, yet sustainable and biodegradable.
Seevix manufactures SVX through biomimicry in a controlled fermenter-based process to create thinner, lighter and tougher products on a commercial scale. SVX is a bioprotein functional silk with the sustainability characteristics of the natural fiber.
Seevix and the ASICS Institute of Sport Science will jointly develop sporting goods utilizing SVX spidersilk.
One of the core strategies in ASICS’s medium-term management plan (“ASICS Growth Plan (AGP) 2020”) is to “Create differentiated innovation”. ASICS has continued to introduce advanced technologies into its products to improve both sustainability and functionality, and has shifted to sustainable materials, including those deriving from biotechnology, by collaborating with external partners. ASICS aims to contribute to a circular economy while creating innovative products, services, and processes that significantly change customers’ lifestyles and experiences.
Seevix was established in 2014. Its patented SVX synthetic spidersilk, backed by over ten years of research at the Hebrew University, is manufactured by means of a single-step production process, enabling scalable, green, commercial manufacturing that reduces production time and costs. Seevix’s exceptional multidisciplinary R&D team of biologists, chemists and material engineers is dedicated to creating next-generation SVX-based products in a host of different industries, providing its partners with a sustainable competitive edge.
Amalia Herszkowicz, CBO and media affairs
SOURCE Seevix Material Sciences Ltd.